Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rutkowski

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|May 20, 2026
Cross-Vendor Validation of Proton Density Fat Fraction and T<sub>1</sub> Mapping Using a Combined Proton Density Fat Fraction-T1 PhantomJitka Starekova, Sebastian Weingärtner, David R Rutkowski, et al.
Cancer Research|February 7, 2012
Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancerJuan R Cubillos-Ruiz, Jason R Baird, Amelia J Tesone, et al.
Cancer Immunology Research|February 23, 2021
Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8<sup>+</sup> T CellsMarit M Melssen, Robin S Lindsay, Katarzyna Stasiak, et al.
Journal of Leukocyte Biology|December 8, 2025
Ovarian cancer drives TLR5-dependent expansion of myeloid progenitors through systemic ligand disseminationSree H Kolli, Mitchell T McGinty, Mirna Perusina Lanfranca, et al.
Cell|June 16, 2015
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell HomeostasisJuan R Cubillos-Ruiz, Pedro C Silberman, Melanie R Rutkowski, et al.
Cancer Discovery|October 4, 2016
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor CellsNikolaos Svoronos, Alfredo Perales-Puchalt, Michael J Allegrezza, et al.
Cancer Research|March 17, 2016
IL15 Agonists Overcome the Immunosuppressive Effects of MEK InhibitorsMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
Journal of Leukocyte Biology|March 15, 2018
Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapyAlfredo Perales-Puchalt, Jairo Perez-Sanz, Kyle K Payne, et al.
Cancer Cell|December 24, 2014
Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammationMelanie R Rutkowski, Tom L Stephen, Nikolaos Svoronos, et al.
Cancer Research|June 23, 2026
Opportunities to enhance cancer research through advocate-researcher partnershipsSarah B Gitto, Savannah Hughes, Marcie Paul, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Journal of Magnetic Resonance Imaging : JMRI|May 20, 2026
Cross-Vendor Validation of Proton Density Fat Fraction and T<sub>1</sub> Mapping Using a Combined Proton Density Fat Fraction-T1 PhantomJitka Starekova, Sebastian Weingärtner, David R Rutkowski, et al.
Cancer Research|February 7, 2012
Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancerJuan R Cubillos-Ruiz, Jason R Baird, Amelia J Tesone, et al.
Cancer Immunology Research|February 23, 2021
Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8<sup>+</sup> T CellsMarit M Melssen, Robin S Lindsay, Katarzyna Stasiak, et al.
Journal of Leukocyte Biology|December 8, 2025
Ovarian cancer drives TLR5-dependent expansion of myeloid progenitors through systemic ligand disseminationSree H Kolli, Mitchell T McGinty, Mirna Perusina Lanfranca, et al.
Cell|June 16, 2015
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell HomeostasisJuan R Cubillos-Ruiz, Pedro C Silberman, Melanie R Rutkowski, et al.
Cancer Discovery|October 4, 2016
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor CellsNikolaos Svoronos, Alfredo Perales-Puchalt, Michael J Allegrezza, et al.
Cancer Research|March 17, 2016
IL15 Agonists Overcome the Immunosuppressive Effects of MEK InhibitorsMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
Journal of Leukocyte Biology|March 15, 2018
Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapyAlfredo Perales-Puchalt, Jairo Perez-Sanz, Kyle K Payne, et al.
Cancer Cell|December 24, 2014
Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammationMelanie R Rutkowski, Tom L Stephen, Nikolaos Svoronos, et al.
Cancer Research|June 23, 2026
Opportunities to enhance cancer research through advocate-researcher partnershipsSarah B Gitto, Savannah Hughes, Marcie Paul, et al.
Pageof 14